Table 1 Demographic and clinical characteristics
|  | Patients (n = 19) | Controls (n = 19) | p-value |
|---|---|---|---|
Age at baseline (years) | 50.2 (8.6) | 49.3 (9.0) | 0.76 |
Education | Â | Â | 0.66 |
High School | 2 | 3 | Â |
College | 8 | 8 | Â |
Undergraduate Degree | 5 | 2 | Â |
Graduate Degree | 4 | 6 | Â |
Menopausal status at baseline | Â | 0.82 | |
Menstruating | 8 | 9 | Â |
Perimenopausal | 4 | 2 | Â |
Postmenopausal | 7 | 8 | Â |
Cancer stage | Â | Â | Â |
I | 3 | – |  |
II | 13 | – |  |
III | 3 | – |  |
Chemotherapy regimen | Â | Â | Â |
FEC-D (six cycles)1 | 12 | – |  |
FEC-D (five cycles) | 1 | Â | Â |
CD (four cycles) | 4 | – |  |
CDOX (four cycles)2 | 2 | – |  |
Type of surgery | Â | Â | Â |
Modified Radical MX | 7 | – |  |
Simple MX | 1 | – |  |
Segmental MX | 3 | – |  |
Lumpectomy | 8 | – |  |
Time between (days) | Â | Â | Â |
Surgery to T1 MRI | 49.9 (15.2) | – |  |
T1 MRI to chemo | 6.2 (4.9) | – |  |
End chemo to T2 MRI | 32.0 (15.3) | – |  |
T1 MRI to T2 MRI | 128.8 (23.0) | 127.0 (25.0) | 0.81 |
T2 MRI to T3 MRI | 406.16 (70.3) | 449.7 (106.9) | 0.15 |